ClinicalTrials.Veeva

Menu

Transcranial Doppler, Optic Nerve Envelope Diameter and Quantitative Pupillometry Measurements (DOPPLER)

C

Centre Hospitalier Universitaire de la Réunion

Status

Enrolling

Conditions

Neurological Complication

Treatments

Other: Non-invasive neuromonitoring evaluation (transcranial doppler, optic nerve envelope diameter and quantitative pupillometry)

Study type

Observational

Funder types

Other

Identifiers

NCT05843214
2021/CHU/04

Details and patient eligibility

About

Non-invasive neuromonitoring tools such as transcranial doppler, optic nerve envelope diameter measurement and quantitative pupillometry are routinely used in acute brain injured patients as part of multimodal neuromonitoring with the aim, among others, of detecting episodes of intracranial hypertension, each method allowing the study of one of the different pathophysiological mechanisms of its impact.

However, at present there is no data in the literature on the value of these non-invasive neuromonitoring tools in the management of patients undergoing controlled intracranial surgery.

The study aims to help the early detection of postoperative neurological deterioration.

Enrollment

230 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Regulated intracranial surgery: scheduled > 48 hours
  • French-speaking patient
  • No opposition from the patient or a relative when the patient is unable to consent

Exclusion criteria

  • Chronic subdural haematoma
  • Isolated cerebral endovascular procedure
  • Stereotactic biopsy
  • Scheduled ventriculoperitoneal shunt or isolated ventriculocisternostomy
  • Specific non-inclusion criteria for quantitative pupillometry: known pupillary abnormalities, glaucoma, cataract surgery and any ocular surgery.

Trial contacts and locations

1

Loading...

Central trial contact

Laetitia BERLY, PhD; Romain ASMOLOV, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems